SPC450
cedazuridine, or a pharmaceutically acceptable salt thereof
Status:
UmsóknApplication date:
21.12.2023Application published:
15.1.2024
Max expiry date:
15.10.2033Medicine name:
InaqoviMedicine for children:
No
Timeline
Today
21.12.2023Application
15.1.2024Publication
15.10.2033Expires
Marketing license
IS authorization number:
EU/1/23/1756Date:
13.10.2023
Foreign authorization number:
EU/1/23/1756Date:
15.9.2023
Owner
Name:
OTSUKA PHARMACEUTICALS CO, Ltd.Address:
2-9, Kanda Tsukasa-machi, Tokyo JP
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105 Reykjavík
Patent
Number:
EP2207786